The pharmaceutical industry seems besieged on all sides, with declining R&D productivity, expiring patents on blockbuster products and relentless downward pricing pressure forcing companies to look closely at the bottom line. One affect of this onslaught has been an upsurge in the level of M&A activity as players within the industry consolidate to cut costs, expand research pipelines and lengthen geographic reach.
23-Jul-2012 - WAPMA and PMGMAN are calling on African Governments to pump more money into R&D in order to boost the continent’s pharmaceutical manufacturing sector.
09-Jul-2012 - Pharma execs are now spending as much time dealing with increasing levels of regulations as they spend on growing their businesses, according to KPMG.
28-Jun-2012 - Bosch Packaging says it is now developing a big batch version of its new X-ray capsule inspection tech.
27-Jun-2012 - PPMA is fearful that the Government of Pakistan’s recent call for more foreign investment in the local pharma sector will go unheard because the industry is already overcrowded.
06-Jun-2012 - AMPAC is selling its aerospace business after deciding it lacked the “horsepower” to grow both it and the pharmaceutical unit.
04-Jun-2012 - The new Generic Drugs User Fee Act (GDUFA) means a “level playing field” for drugmakers, according to SOCMA members.
04-Jun-2012 - AptarGroup is buying Stelmi for €165m ($205m) to expand into primary packaging components for injectable delivery devices.
31-May-2012 - Patheon says its new soft gel platform is creating cheaper development opportunities for drugsmakers.
29-May-2012 - Biopharma mergers are a “key problem” for manufacturing quality teams as the loss of focus can lead to regulatory actions, a compliance expert said.
12-Apr-2012 - in-PharmaTechnologist brings you a round-up of the latest new facilities and expansions for drugsmakers, including added cytotoxic capabilities for BTL, Jubilant’s launch of a special economic zone in India and plans...
08-Feb-2012 - Cambrex expects fine chemical consolidation to continue this year and is being “proactive” in its hunt for takeover targets.
27-Jan-2012 - Danone and Mead Johnson may make a joint bid for the €8bn infant nutrition-dominated Pfizer nutrition business that is up for sale, according to press reports.
23-Jan-2012 - UK-based Polytherics has acquired Warwick Effect Polymers (WEP) to expand biologic drug modification offering.
12-Jan-2012 - NantWorks has unveiled plans to pump $85.5m into a new oncology and critical care injectables manufacturing plant in Terre Haute, Indiana.
10-Jan-2012 - Zhongxi Sunve has bought a stake in a Chinese oncology API manufacturer and has further takeovers in the pipeline.
09-Jan-2012 - Rousselot says its acquisition of Eastman Kodak’s Gel Corporation will boost its gelatine production capacity and help it meet soaring drug industry demand.
05-Jan-2012 - R&D software firm Accelrys says it will speed up the pharma QA/QC process and reduce the compliance risk ten-fold through its $35m takeover of VelQuest.
22-Dec-2011 - Pall will buy US instrument maker ForteBio next year in a continuation of efforts to build its biomanufacturing technology offering.
01-Dec-2011 - India-based Vivimed Labs is buying Uquifa for £35m ($55m) to add API capabilities in Europe and Latin America.
17-Nov-2011 - Ashland expects integration of ISP and demand for pharma ingredients to drive “accelerated growth” in the next few years.
05-Oct-2011 - Active pharmaceutical ingredient (API) manufacturer ScinoPharm has gone public in a bid to raise funds for its upcoming expansions.
20-Sep-2011 - Chemicals supplier Lubrizol was bought by Warren Buffet’s Berkshire Hathaway group last week in a deal worth $9.7bn (€7.1bn)
07-Sep-2011 - AmerisourceBergen has bought informatics firm IntrinsiQ for $35m (€25m) continuing the spending spree it began earlier this week with the acquisition of market access consultancy Premier Source.
06-Sep-2011 - Chesapeake will buy leaflet and label maker Cortegra to strengthen its manufacturing position in the US pharmaceutical packaging market.
31-Aug-2011 - DMV-Fonterra excipients (DFE) will buy Indian manufacturer Brahmar Cellulose Private Limited (BCPL) to strengthen its position in the pharmaceutical excipient market and reduce costs.